• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of aacPermissionsJournals.ASM.orgJournalAAC ArticleJournal InfoAuthorsReviewers
Antimicrob Agents Chemother. Oct 1987; 31(10): 1451–1456.
PMCID: PMC174969

Trimethoprim resistance.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Acar JF, Goldstein FW. Genetic aspects and epidemiologic implications of resistance to trimethoprim. Rev Infect Dis. 1982 Mar-Apr;4(2):270–275. [PubMed]
  • Allegra CJ, Kovacs JA, Drake JC, Swan JC, Chabner BA, Masur H. Activity of antifolates against Pneumocystis carinii dihydrofolate reductase and identification of a potent new agent. J Exp Med. 1987 Mar 1;165(3):926–931. [PMC free article] [PubMed]
  • Alvarez S, DeMaria A, Jr, Kulkarni R, Klein JO, McCabe WR. Interactions of rifampin and trimethoprim in vitro. Rev Infect Dis. 1982 Mar-Apr;4(2):390–401. [PubMed]
  • Amyes SG. Epidemiology of trimethoprim resistance. J Antimicrob Chemother. 1986 Oct;18 (Suppl 100):215–221. [PubMed]
  • Amyes SG, Doherty CJ, Wonnacott S. Trimethoprim and co-trimoxazole: a comparison of their use in respiratory tract infections. Scand J Infect Dis. 1986;18(6):561–566. [PubMed]
  • Amyes SG, Doherty CJ, Young HK. High-level trimethoprim resistance in urinary bacteria. Eur J Clin Microbiol. 1986 Jun;5(3):287–291. [PubMed]
  • Amyes SG, Smith JT. R-factor trimethoprim resistance mechanism: an insusceptible target site. Biochem Biophys Res Commun. 1974 May 20;58(2):412–418. [PubMed]
  • Amyes SG, Smith JT. Thymineless mutants and their resistance to trimethoprim. J Antimicrob Chemother. 1975 Mar;1(1):85–89. [PubMed]
  • Archer GL, Coughter JP, Johnston JL. Plasmid-encoded trimethoprim resistance in staphylococci. Antimicrob Agents Chemother. 1986 May;29(5):733–740. [PMC free article] [PubMed]
  • Barth PT, Datta N, Hedges RW, Grinter NJ. Transposition of a deoxyribonucleic acid sequence encoding trimethoprim and streptomycin resistances from R483 to other replicons. J Bacteriol. 1976 Mar;125(3):800–810. [PMC free article] [PubMed]
  • Broad DF, Smith JT. Classification of trimethoprim-resistant dihydrofolate reductases mediated by R-plasmids using isoelectric focussing. Eur J Biochem. 1982 Jul;125(3):617–622. [PubMed]
  • Brumfitt W, Hamilton-Miller JM. Use of trimethoprim alone or in combination with drugs other than sulfonamides. Rev Infect Dis. 1982 Mar-Apr;4(2):402–410. [PubMed]
  • Brumfitt W, Hamilton-Miller JM, Havard CW, Tansley H. Trimethoprim alone compared to co-trimoxazole in lower respiratory infections: pharmacokinetics and clinical effectiveness. Scand J Infect Dis. 1985;17(1):99–105. [PubMed]
  • Burchall JJ. The development of the diaminopyrimidines. J Antimicrob Chemother. 1979 Nov;5(B):3–14. [PubMed]
  • Burchall JJ, Elwell LP, Fling ME. Molecular mechanisms of resistance to trimethoprim. Rev Infect Dis. 1982 Mar-Apr;4(2):246–254. [PubMed]
  • Bushby SR. Trimethoprim-sulfamethoxazole: in vitro microbiological aspects. J Infect Dis. 1973 Nov;128(Suppl):442–p. [PubMed]
  • Bushby SR, Hitchings GH. Trimethoprim, a sulphonamide potentiator. Br J Pharmacol Chemother. 1968 May;33(1):72–90. [PMC free article] [PubMed]
  • Chen GX, Mueller C, Wendlinger M, Zolg JW. Kinetic and molecular properties of the dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant clones of the human malaria parasite Plasmodium falciparum. Mol Pharmacol. 1987 Apr;31(4):430–437. [PubMed]
  • Chirnside ED, Emmerson AM, Smith JT. A follow-up survey of transferable, plasmid-encoded trimethoprim resistance in a general hospital (1975-1983). J Antimicrob Chemother. 1985 Oct;16(4):419–434. [PubMed]
  • Crider SR, Colby SD. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother. 1985 Jan;27(1):71–75. [PMC free article] [PubMed]
  • Datta N, Dacey S, Hughes V, Knight S, Richards H, Williams G, Casewell M, Shannon KP. Distribution of genes for trimethoprim and gentamicin resistance in bacteria and their plasmids in a general hospital. J Gen Microbiol. 1980 Jun;118(2):495–508. [PubMed]
  • Datta N, Hedges RW. Trimethoprim resistance conferred by W plasmids in Enterobacteriaceae. J Gen Microbiol. 1972 Sep;72(2):349–355. [PubMed]
  • Dornbusch K, Toivanen P. Effect of trimethoprim or trimethoprim/sulphamethoxazole usage on the emergence of trimethoprim resistance in urinary tract pathogens. Scand J Infect Dis. 1981;13(3):203–210. [PubMed]
  • Farrar WE. Antibiotic resistance in developing countries. J Infect Dis. 1985 Dec;152(6):1103–1106. [PubMed]
  • Fleming MP, Datta N, Grüneberg RN. Trimethoprim resistance determined by R factors. Br Med J. 1972 Mar 18;1(5802):726–728. [PMC free article] [PubMed]
  • Flensburg J, Sköld O. Regulatory changes in the formation of chromosomal dihydrofolate reductase causing resistance to trimethoprim. J Bacteriol. 1984 Jul;159(1):184–190. [PMC free article] [PubMed]
  • Flensburg J, Sköld O. Massive overproduction of dihydrofolate reductase in bacteria as a response to the use of trimethoprim. Eur J Biochem. 1987 Feb 2;162(3):473–476. [PubMed]
  • Flensburg J, Steen R. Nucleotide sequence analysis of the trimethoprim resistant dihydrofolate reductase encoded by R plasmid R751. Nucleic Acids Res. 1986 Jul 25;14(14):5933–5933. [PMC free article] [PubMed]
  • Fling ME, Richards C. The nucleotide sequence of the trimethoprim-resistant dihydrofolate reductase gene harbored by Tn7. Nucleic Acids Res. 1983 Aug 11;11(15):5147–5158. [PMC free article] [PubMed]
  • Fling ME, Walton L, Elwell LP. Monitoring of plasmid-encoded, trimethoprim-resistant dihydrofolate reductase genes: detection of a new resistant enzyme. Antimicrob Agents Chemother. 1982 Nov;22(5):882–888. [PMC free article] [PubMed]
  • Goldstein FW, Papadopoulou B, Acar JF. The changing pattern of trimethoprim resistance in Paris, with a review of worldwide experience. Rev Infect Dis. 1986 Sep-Oct;8(5):725–737. [PubMed]
  • Goodhart GL. In vivo v in vitro susceptibility of enterococcus to trimethoprim-sulfamethoxazole. A pitfall. JAMA. 1984 Nov 16;252(19):2748–2749. [PubMed]
  • Grüneberg RN, Emmerson AM, Ridgway GL. Rifampicin-containing antibiotic combinations in the treatment of difficult infections. J Antimicrob Chemother. 1984 Jun;13 (Suppl 100):49–55. [PubMed]
  • Gutmann L, Williamson R, Moreau N, Kitzis MD, Collatz E, Acar JF, Goldstein FW. Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia. J Infect Dis. 1985 Mar;151(3):501–507. [PubMed]
  • Hamilton-Miller JM, Purves D. Enterococci and antifolate antibiotics. Eur J Clin Microbiol. 1986 Aug;5(4):391–394. [PubMed]
  • Hammerschlag MR. Activity of trimethoprim-sulfamethoxazole against Chlamydia trachomatis in vitro. Rev Infect Dis. 1982 Mar-Apr;4(2):500–505. [PubMed]
  • Hedges RW, Datta N, Fleming MP. R factors conferring resistance to trimethoprim but not sulphonamides. J Gen Microbiol. 1972 Dec;73(3):573–575. [PubMed]
  • Hitchings GH. Mechanism of action of trimethoprim-sulfamethoxazole. I. J Infect Dis. 1973 Nov;128(Suppl):433–p. [PubMed]
  • Huovinen P. Recording of antimicrobial resistance of urinary tract isolates--effect of repeat samples on resistance levels. J Antimicrob Chemother. 1985 Oct;16(4):443–447. [PubMed]
  • Huovinen P, Mäntyjärvi R, Toivanen P. Trimethoprim resistance in hospitals. Br Med J (Clin Res Ed) 1982 Mar 13;284(6318):782–784. [PMC free article] [PubMed]
  • Huovinen P, Mattila T, Kiminki O, Pulkkinen L, Huovinen S, Koskela M, Sunila R, Toivanen P. Emergence of trimethoprim resistance in fecal flora. Antimicrob Agents Chemother. 1985 Aug;28(2):354–356. [PMC free article] [PubMed]
  • Huovinen P, Pulkkinen L, Helin HL, Mäkilä M, Toivanen P. Emergence of trimethoprim resistance in relation to drug consumption in a Finnish hospital from 1971 through 1984. Antimicrob Agents Chemother. 1986 Jan;29(1):73–76. [PMC free article] [PubMed]
  • Huovinen P, Renkonen OV, Pulkkinen L, Sunila R, Grönroos P, Klossner ML, Virtanen S, Toivanen P. Trimethoprim resistance of Escherichia coli in outpatients in Finland after ten years' use of plain trimethoprim. J Antimicrob Chemother. 1985 Oct;16(4):435–441. [PubMed]
  • Jacoby GA. Perils of prophylaxis. N Engl J Med. 1982 Jan 7;306(1):43–44. [PubMed]
  • Joyner SS, Fling ME, Stone D, Baccanari DP. Characterization of an R-plasmid dihydrofolate reductase with a monomeric structure. J Biol Chem. 1984 May 10;259(9):5851–5856. [PubMed]
  • Kasanen A, Sundquist H. Trimethoprim alone in the treatment of urinary tract infections: eight years of experience in Finland. Rev Infect Dis. 1982 Mar-Apr;4(2):358–365. [PubMed]
  • King CH, Shlaes DM, Dul MJ. Infection caused by thymidine-requiring, trimethoprim-resistant bacteria. J Clin Microbiol. 1983 Jul;18(1):79–83. [PMC free article] [PubMed]
  • Kraft CA, Timbury MC, Platt DJ. Distribution and genetic location of Tn7 in trimethoprim-resistant Escherichia coli. J Med Microbiol. 1986 Sep;22(2):125–131. [PubMed]
  • Lacey RW. Do sulphonamide-trimethoprim combinations select less resistance to trimethoprim than the use of trimethoprim alone? J Med Microbiol. 1982 Nov;15(4):403–427. [PubMed]
  • Lacey RW, Lord VL, Gunasekera HK, Leiberman PJ, Luxton DE. Comparison of trimethoprim alone with trimethoprim sulphamethoxazole in the treatment of respiratory and urinary infections with particular reference to selection of trimethoprim resistance. Lancet. 1980 Jun 14;1(8181):1270–1273. [PubMed]
  • Lichtenstein C, Brenner S. Unique insertion site of Tn7 in the E. coli chromosome. Nature. 1982 Jun 17;297(5867):601–603. [PubMed]
  • Lyon BR, Skurray R. Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiol Rev. 1987 Mar;51(1):88–134. [PMC free article] [PubMed]
  • Martin DC, Arnold JD. Trimethroprim and sulfalene therapy of Plasmodium vivax. J Clin Pharmacol J New Drugs. 1969 May-Jun;9(3):155–159. [PubMed]
  • Matthews DA, Bolin JT, Burridge JM, Filman DJ, Volz KW, Kraut J. Dihydrofolate reductase. The stereochemistry of inhibitor selectivity. J Biol Chem. 1985 Jan 10;260(1):392–399. [PubMed]
  • Matthews DA, Smith SL, Baccanari DP, Burchall JJ, Oatley SJ, Kraut J. Crystal structure of a novel trimethoprim-resistant dihydrofolate reductase specified in Escherichia coli by R-plasmid R67. Biochemistry. 1986 Jul 29;25(15):4194–4204. [PubMed]
  • Mayer KH, Fling ME, Hopkins JD, O'Brien TF. Trimethoprim resistance in multiple genera of Enterobacteriaceae at a U.S. hospital: spread of the type II dihydrofolate reductase gene by a single plasmid. J Infect Dis. 1985 May;151(5):783–789. [PubMed]
  • Murray BE, Alvarado T, Kim KH, Vorachit M, Jayanetra P, Levine MM, Prenzel I, Fling M, Elwell L, McCracken GH, et al. Increasing resistance to trimethoprim-sulfamethoxazole among isolates of Escherichia coli in developing countries. J Infect Dis. 1985 Dec;152(6):1107–1113. [PubMed]
  • Murray BE, Rensimer ER. Transfer of trimethoprim resistance from fecal Escherichia coli isolated during a prophylaxis study in Mexico. J Infect Dis. 1983 Apr;147(4):724–728. [PubMed]
  • Murray BE, Rensimer ER, DuPont HL. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole. N Engl J Med. 1982 Jan 21;306(3):130–135. [PubMed]
  • Najjar A, Murray BE. Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci. Antimicrob Agents Chemother. 1987 May;31(5):808–810. [PMC free article] [PubMed]
  • Noall EW, Sewards HF, Waterworth PM. Successful Treatment of a Case of Proteus Septicaemia. Br Med J. 1962 Oct 27;2(5312):1101–1102. [PMC free article] [PubMed]
  • O'Brien TF, Acar JF, Altmann G, Blackburn BO, Chao L, Courtieu AL, Evans DA, Guzman M, Holmes M, Jacobs MR, et al. Laboratory surveillance of synergy between and resistance to trimethoprim and sulfonamides. Rev Infect Dis. 1982 Mar-Apr;4(2):351–357. [PubMed]
  • Papadopoulou B, Gerbaud G, Courvalin P, Acar JF, Goldstein FW. Molecular epidemiology of resistance to trimethoprim in enterobacteria isolated in a Parisian hospital. Ann Inst Pasteur Microbiol. 1986 May-Jun;137A(3):239–251. [PubMed]
  • Pattishall KH, Acar J, Burchall JJ, Goldstein FW, Harvey RJ. Two distinct types of trimethoprim-resistant dihydrofolate reductase specified by R-plasmids of different compatibility groups. J Biol Chem. 1977 Apr 10;252(7):2319–2323. [PubMed]
  • Pulkkinen L, Huovinen P, Vuorio E, Toivanen P. Characterization of trimethoprim resistance by use of probes specific for transposon Tn7. Antimicrob Agents Chemother. 1984 Jul;26(1):82–86. [PMC free article] [PubMed]
  • Salter AJ. Trimethoprim-sulfamethoxazole: an assessment of more than 12 years of use. Rev Infect Dis. 1982 Mar-Apr;4(2):196–236. [PubMed]
  • Shapiro JA, Sporn P. Tn402: a new transposable element determining trimethoprim resistance that inserts in bacteriophage lambda. J Bacteriol. 1977 Mar;129(3):1632–1635. [PMC free article] [PubMed]
  • Simonsen CC, Chen EY, Levinson AD. Identification of the type I trimethoprim-resistant dihydrofolate reductase specified by the Escherichia coli R-plasmid R483: comparison with procaryotic and eucaryotic dihydrofolate reductases. J Bacteriol. 1983 Sep;155(3):1001–1008. [PMC free article] [PubMed]
  • Sköld O, Boethius G, Steen R. Correlation of drug utilization data for trimethoprim in a defined population with patterns of resistance among bacteria causing urinary tract infections. Scand J Infect Dis. 1986;18(5):451–455. [PubMed]
  • Sköld O, Widh A. A new dihydrofolate reductase with low trimethoprim sensitivity induced by an R factor mediating high resistance to trimethoprim. J Biol Chem. 1974 Jul 10;249(13):4324–4325. [PubMed]
  • Smith DR, Calvo JM. Nucleotide sequence of the E coli gene coding for dihydrofolate reductase. Nucleic Acids Res. 1980 May 24;8(10):2255–2274. [PMC free article] [PubMed]
  • Smith HW. Mutants of Klebsiella pneumoniae resistant to several antibiotics. Nature. 1976 Jan 29;259(5541):307–308. [PubMed]
  • Smith SL, Stone D, Novak P, Baccanari DP, Burchall JJ. R plasmid dihydrofolate reductase with subunit structure. J Biol Chem. 1979 Jul 25;254(14):6222–6225. [PubMed]
  • Steen R, Sköld O. Plasmid-borne or chromosomally mediated resistance by Tn7 is the most common response to ubiquitous use of trimethoprim. Antimicrob Agents Chemother. 1985 Jun;27(6):933–937. [PMC free article] [PubMed]
  • Stone D, Smith SL. The amino acid sequence of the trimethoprim-resistant dihydrofolate reductase specified in Escherichia coli by R-plasmid R67. J Biol Chem. 1979 Nov 10;254(21):10857–10861. [PubMed]
  • Sundström L, Vinayagamoorthy T, Sköld O. Novel type of plasmid-borne resistance to trimethoprim. Antimicrob Agents Chemother. 1987 Jan;31(1):60–66. [PMC free article] [PubMed]
  • Swift G, McCarthy BJ, Heffron F. DNA sequence of a plasmid-encoded dihydrofolate reductase. Mol Gen Genet. 1981;181(4):441–447. [PubMed]
  • Tennhammar-Ekman B, Sköld O. Trimethoprim resistance plasmids of different origin encode different drug-resistant dihydrofolate reductases. Plasmid. 1979 Jul;2(3):334–346. [PubMed]
  • Tennhammar-Ekman B, Sundström L, Sköld O. New observations regarding evolution of trimethoprim resistance. J Antimicrob Chemother. 1986 Oct;18 (Suppl 100):67–76. [PubMed]
  • Then RL. Mechanisms of resistance to trimethoprim, the sulfonamides, and trimethoprim-sulfamethoxazole. Rev Infect Dis. 1982 Mar-Apr;4(2):261–269. [PubMed]
  • Then RL, Angehrn P. Low trimethoprim susceptibility of anaerobic bacteria due to insensitive dihydrofolate reductases. Antimicrob Agents Chemother. 1979 Jan;15(1):1–6. [PMC free article] [PubMed]
  • Towner KJ, Slack RC. Effect of changing selection pressures on trimethoprim resistance in Enterobacteriaceae. Eur J Clin Microbiol. 1986 Oct;5(5):502–506. [PubMed]
  • Towner KJ, Wise PJ, Lewis MJ. Molecular relationships between trimethoprim R plasmids obtained from human and animal sources. J Appl Bacteriol. 1986 Dec;61(6):535–540. [PubMed]
  • Traub WH, Kleber I. Selected and spontaneous variants of Serratia marcescens with combined resistance against chloramphenicol, nalidixic acid, and trimethoprim. Chemotherapy. 1977;23(6):436–451. [PubMed]
  • Villafranca JE, Howell EE, Voet DH, Strobel MS, Ogden RC, Abelson JN, Kraut J. Directed mutagenesis of dihydrofolate reductase. Science. 1983 Nov 18;222(4625):782–788. [PubMed]
  • Wallace RJ, Jr, Wiss K, Bushby MB, Hollowell DC. In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria. Rev Infect Dis. 1982 Mar-Apr;4(2):326–331. [PubMed]
  • Young HK, Amyes SG. Characterisation of a new transposon-mediated trimethoprim-resistant dihydrofolate reductase. Biochem Pharmacol. 1985 Dec 15;34(24):4334–4337. [PubMed]
  • Young HK, Amyes SG. A new mechanism of plasmid trimethoprim resistance. Characterization of an inducible dihydrofolate reductase. J Biol Chem. 1986 Feb 25;261(6):2503–2505. [PubMed]
  • Young HK, Jesudason MV, Koshi G, Amyes SG. Unusual expression of new low-level-trimethoprim-resistance plasmids. J Clin Microbiol. 1986 Jul;24(1):61–64. [PMC free article] [PubMed]
  • Young HK, Skurray RA, Amyes SG. Plasmid-mediated trimethoprim-resistance in Staphylococcus aureus. Characterization of the first gram-positive plasmid dihydrofolate reductase (type S1). Biochem J. 1987 Apr 1;243(1):309–312. [PMC free article] [PubMed]
  • Zervos MJ, Schaberg DR. Reversal of the in vitro susceptibility of enterococci to trimethoprim-sulfamethoxazole by folinic acid. Antimicrob Agents Chemother. 1985 Sep;28(3):446–448. [PMC free article] [PubMed]
  • Zolg JW, Hänggi UJ. Characterization of a R plasmid-associated, trimethoprim-resistant dihydrofolate reductase and determination of the nucleotide sequence of the reductase gene. Nucleic Acids Res. 1981 Feb 11;9(3):697–710. [PMC free article] [PubMed]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

Formats: